Transfusión de concentrado de hematíes e infección posquirúrgica en pacientes críticos

Medicina Clinica

Volumn 115, Issue 16, 2000, Pages 625-629

  Leal, Santiago Ramón ^a   Jara, Irene ^a   Román, Ma José ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Critically ill patient; Immunomodulation; Mediastinitis; Nosocomial pneumonia; Postoperative infections; Red blood cells concentrates; Transfusion

Indexed keywords

ANTIBODY PRODUCTION; CELLULAR IMMUNITY; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOLOGY; INFECTION; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW;

ANTIBODY FORMATION; ERYTHROCYTE TRANSFUSION; HUMANS; IMMUNITY, CELLULAR; INFECTION; POSTOPERATIVE COMPLICATIONS;

EID: 0034638676     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(00)71642-3     Document Type: Article

References (58)

1. Haller M, Forst H. Red cell transfusion therapy in the critical care setting. Transf Sci 1997; 18: 459-477.
2. Shoemaker WC, Appel PL, Kram HB, Waxmank K, Lee TS. Prospective trial of supranormal values of survivors as therapeutics goals in high-risk surgical patients. Chest 1988; 94: 1176-1186.
3. Hébert PC, Wells G, Tweeddale M, Martin C, Marshall J, Pham B et al. Does transfusion practice affect mortality in critically ill patients? Am J Respir Crit Care Med 1997; 155: 1618-1623.
4. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. Retrovirus epidemiology donor study. The risk of transfusion-transmitted viral infections. M Engl J Med 1996; 334: 1685-1690.
5. Goodnough LT, Johnston MFM, Toy PTCY. Transfusion Medicine Academic Award Group. The variability of transfusion practice in coronary artery bypass graft surgery. JAMA 1991; 265: 86-90.
6. Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognon G, Pesenti A et al. A trial a goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333: 1025-1032.
7. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-417.
8. Johnson RG, Thurer RL, Krusxall MS, Sirois C, Gervino EV, Critchlow J et al. Comparison of two transfusion strategies after elective operations for myocardial revascularization. J Thorac Cardiovasc Surg 1992; 104: 307-314.
9. Spiess BD, Ley C, Body SC, Siegel LC, Stover EP, Maddi R et al. Hemalocrit value on intensive care unit entry influences the frecuency of Q-wave myocardial infarction after coronary artery bypass grafting. J Thorac Cardiovasc Surg 1998; 116: 460-467.
10. Blumberg N. Allogeneic transfusion and infection: economic and clinical implications. Semin Hematol 1997; 34: 34-38.
11. Blumberg N, Heal JM. Immunomodulation by blood transfusion: an evolving scientific and clinical challenge. Am J Med 1996; 101: 299-308.
12. Tartter PI, Mohandas K, Azar P, Endres J, Kaplan J, Spivack M. Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery. Am J Surg 1998; 176: 462-466.
13. Vanvakas EC, Carven JH. Allogeneic blood transfusion, hospital charges, and lenght of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection. Arch Pathol Lab Med 1998; 122: 145-151.
14. Klein HG. Immunomodulatory aspects of transfusion. Anesthesiology 1999; 91: 861-865.
15. Nielsen HJ, Reimert CM, Pedersen AN, Brunner N, Edvardsen L, Dybkjaer E et al. Time-dependent, spontaneus release of white cell- and platelet-derived bioactive substances from scred human blood. Transfusion 1996; 36: 960-965.
16. Hammer JH, Mynster T, Reimert CM, Pedersen AN, Nielsen HJ. Reduction of bioactive substances in stored donor blood: prestorage versus bedside leucofiltration. Eur J Haematol 1999; 63: 29-34.
17. Nielsen HJ, Edvarsen L, Vangsgaard K, Dybkjaer E, Skov PS. Time-dependent histamine release from stored human blood products. Br J Surg 1996; 83: 259-262.
18. Kluter H, Schlenke P, Muller-Steinhardt M, Paulsen M, Kirchner H. Impact of buffy coat storage on the generation of inflammatory cytokines and platelet activation. Transfusion 1997; 37: 362-367.
19. Kristiansson M, Soop M, Shanwell A, Sundqvist KG. Prestorage versus bedside blood cell filtration of red blood cell concentrates: effects on the content of cytokines and soluble tumor necrosis factor receptors. J Trauma 1996; 40: 379-383.
20. Landers DF, Hill GE, Wong KC, Fox IJ. Blood transfusion-induced immunomodulation. Anesth Analg 1996; 82: 187-204.
21. Waymack JP, Balakrishnank K, McNeal N, Gonsen S, Miskell P, Warden GD et al. Effect of blood transfusions on macrofage-lymphocyte interaction in an animal model. Ann Surgery 1986; 204: 681-685.
22. Snyder EL, Mosher DF, Hezzey A, Golensky G. Effect of blood transfusion on in vivo levels ol plasma fibronectin. J Lab Clin Med 1981; 98: 336-341.
23. Vamvakas EC, Carven JH. Length of storage of transfused red cells and postoperative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion 2000; 40: 101-109.
24. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973; 5: 253-259.
25. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, LeChance JG et al. Prospective evaluation or pretransplant blood transfusion in cadaver kidney recipients. Transplantation 1997; 63: 964-967.
26. Gantt CL. Red blood cells for cancer patients. Lancet 1981; 2: 363.
27. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986; 152: 479-482.
28. Tartter PI. Blood transfusions and infectious complications following coiorectal cancer surgery. Br J Surg 1988; 75: 789-792.
29. Tartter PI, Driefuss RM, Malon AM, Heimann TM, Aufses AH. Relationship of postoperative septic complications and blood transfusion in patients with Crohn's disease. Am J Surg 1988; 155: 43-48.
30. Braga M, Vignali A, Radaelli G, Gianotti L, Di Carlo V. Association between perioperative blood transfusion and postoperative infection in patients having elective operations for gastrointestinal cancer. Eur J Surg 1992; 158: 531-536.
31. Vignali A, Braga M, Gianotti L, Radaelli G, Gentilinio O, Russo A et al. A single unit of transfused allogeneic blood increases postoperative infections. Vox Sang 1996; 71: 170-175.
32. Miholic J, Hudec M, Domanig E, Hiertz H, Klepetko W, Lackner F et al. Risk factors for severe bacterial infections after valve replacement and aortocoronary bypass operations: analysis of 246 cases by logistic regression. Ann Thorac Surg 1985; 40: 224-228.
33. Ottino G, De Paulis R, Pansini, Rocca G, Tallone MV, Comoglio C et al. Major sternal wound infection after open-heart surgery: a multivariate analysis of risk factors in 2,579 consecutive operative procedures. Ann Thorac Surg 1987; 44: 173-179.
34. Murphy PJ, Connery C, Hicks GL, Blumberg N. Homologous blood transfusion as a risk factor for postoperative infection after coronary bypass graft operations. J Thorac Cardiovasc Surg 1992; 104: 1092-1099.
35. El Oakley R, Paul E, Wong PS, Yohana A, Vlagee P, Walesby R et al. Mediastinitis in patient undergoing cardiopulmonary bypass: risk analysis and misterm results. J Cardiovasc Surg 1997; 38: 595-600.
36. Zacharias A, Habib RH. Factors predisposing to median sternotomy complications. Deep vs superficial infection. Chest 1996; 110: 1173-1178.
37. Rebollo MH, Bernal JM, Llorca J, Rebasa JM, Revuelta JM. Nosocomial infections in patients having cardiovascular operations: a multivariate analysis of risk factors. J Thorac Cardiovasc Surg 1996; 112: 908-913.
38. Van Watering LMG, Hermans J, Houbiers JGA, Van den Broek PJ, Bouter H, Boer F et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery. A randomized clinical trial. Circulation 1998; 97: 562-568.
39. Vamvakas EC, Carven JH. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery. Effect of the length of storage of transfused red cell. Transfusion 1999; 39: 701-710.
40. Leal SR, Márquez JA, Garcia-Curiel A, Camacho P, Rincón MD, Ordoñez A et al. Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med 2000; 28: 935-940.
41. Ryan T, McCarthy JF, Rady MY, Sarkey J, Gordon S, Starr NJ et al. Early bloodstream infection after cardiopulmonary bypass: frequency rate, risk factors, and implications. Crit Care Med 1997; 25: 2009-2014.
42. Rosemurgy AS, Hart MB, Murphy CG, Albrink MH, Piazza A, Leparc GF et al. Infection after injury: association with blood transfusion. Am Surg 1992; 58; 104-107.
43. Edna TH, Bjerkeset T. Association between blood transfusion and infection in injured patients. J Trauma 1992; 33: 659-661.
44. Costa OL, Colombo CA, Faintuch J. Repercussions of blood transfusions on postoperative complications in patients with multiple trauma. Rev Hosp Clin Fac Med Sao Paulo 1989; 44: 139-142.
45. Duke BJ, Modin GW, Schect WP, Horn JK. Transfusion significantly increases the risk for infection after splenic injury. Arch Surg 1993; 128: 1125-1130.
46. Zallen G, Offner PJ, Moore EE, Blackwell J, Ciesla DJ, Gabriel J et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999; 178: 570-572.
47. Patel R, Portela D, Badley AD, Harmsen WS, Larson-Keller JJ, Ilstrup DM et al. Risk factors of invasive candida and non-candida furgal infections after liver transplantation. Transplantation 1996; 62: 926-934.
48. Lee H, Hawker FH, Selby W, McWilliam DB, Herkes RG. Intensive care treatment of patients with bleeding esophageal varices: results, predictors of mortality, and predictors of the adult respiratory distress syndrome. Crit Care Med 1992; 20: 1555-1563.
49. Fransen E, Maessen J, Dentener M, Senden N, Baurman W. Impact of blood transfusion of inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-1239.
50. Mynster T, Nielsen HJ. The impact of storage time of transfused blood on postoperative infectious complications in rectal cancer surgery. Danish RANX05 colorectal cancer study group. Scand J Gastroenterol 2000; 35: 212-217.
51. Vanvakas EC. Transfusion-associated cancer recurrence and postoperative infection: meta-analyss of randomized, controlled clinical trials. Transfusion 1996; 36: 175-186.
52. Jensen LS, Andersen AJ, Christiansen PM, Hokland P, Juhl CO, Madsen G et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 613-616.
53. Bush OR, Hop WC, Hoynck van Papendrecht MA, Marquet RL, Jeekel J. Blood transfusion and prognosis in colorectal cancer. N Engl J Med 1993; 328: 1372-1376.
54. Heiss MM, Mempel W, Jauch KW, Delanoff C, Mayer G, Mempel M et al. Beneficial effect of autologous blood transfusion on infectious complications after colorectal surgery. Lancet 1993; 342: 1328-1333.
55. Jensen LS, Kissmeyer-Nielsen P, Wolff B, Qvist N. Randomised comparison of leucocyte-depleted versus buffy-coat-poor blood transfusion ard complications after colorectal surgery. Lancet 1996; 348: 841-845.
56. Houbiers JG, Van de Velde CJ, Van de Watering LM, Hermans J, Schreuder S, Bijnen AB et al. Transfusion of red cells is associated with increased incidence of bacterial infection alter colorectal surgery: a prospective study. Transfusion 1997; 37: 126-134.
57. McAlister FA, Clark HD, Wells PS, Laupacis A. Perioperative allogeneic blood transfusion does not cause adverse sequele in patients with cancer a meta-analysis of unconfounded studies. Br J Surg 1998; 85: 171-178.
58. Blajchman MA. Allogeneic blood transfusions, immunomodulation, and postoperative bacteria infection: do we have the answers yet? Transfusion 1997; 37: 121-125.